The purpose of this study is to look at the safety of Precedex when it was used to calm children at procedures or tests under actual medical practice in Japan. This study is seeking for children who are 1 month to less than 18 years old. The patients are planned to be looked over: * From the time of patient check before receiving Precedex * To 1 hour after the completion or stop of using Precedex.
Study Type
OBSERVATIONAL
Enrollment
111
\<Sedation of non-invasive procedures and tests without intubation in pediatrics\> For children aged 2 years or older, the usual dosage of dexmedetomidine is 12 μg/kg/hr given as a continuous intravenous infusion over 10 minutes (initial loading dose) followed by a maintenance dose of 1.5 μg/kg/hr (maintenance dose). For children aged 1 month to \< 2 years old, the usual dosage of dexmedetomidine is 9 μg/kg/hr given as a continuous intravenous infusion over 10 minutes (initial loading dose) followed by a maintenance dose of 1.5 μg/kg/hr (maintenance dose). The infusion rate should be reduced according to patient's condition.
Pfizer
Toykyo, Japan
Number of participants with adverse drug reactions (ADRs)
Time frame: From the time of patient assessment before the start of administration of Precedex to 1 hour after the completion or discontinuation of administration
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.